Digital health and technologies offer a wealth of opportunities, but digital needs to become part of a company’s DNA to achieve transformation. Rodamni Peppa, Boston Scientific’s vice-president for business strategy & commercial excellence for Europe, the Middle East and Africa, gives insight into a four-year digital journey with Dr Paul Tunnah at the 2021 Frontiers Health conference in Milan.
Digital transformation has long been heralded the future of health. Supercharged by COVID-19 necessity, it has become the buzz phrase that slots swiftly into any debate about the future of pharma and healthcare.
Although it features in every forward-thinking analysis and wish list, it is rare to get an insight into what that means across a company, from factory or laboratory floor to boardroom and how a company’s mechanics – often established over decades of practice – can be re-tuned for a digital age.
The internal overhaul is often the missing piece in digital calibration. Boston Scientific’s vice-president for business strategy & commercial excellence for Europe, the Middle East and Africa Rodamni Peppa reveals that it is not as simple as flicking a switch to light up performance. Instead, it takes strategic thinking, practical assessments, meticulous planning, engagement and hard work across a range of metrics.
“My job in the last four or five years has focused dramatically on digital; how do we bring the right messages to the right customers at the right time, and there was no better tool than digital to bring that forward,” says Peppa.
This post was originally published on Source Link